# Xolair Treatment for Milk Allergic Children

> **NCT00968110** · EARLY_PHASE1 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 10 (actual)

## Conditions studied

- Milk Allergy

## Interventions

- **DRUG:** omalizumab

## Key facts

- **NCT ID:** NCT00968110
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968110, "Xolair Treatment for Milk Allergic Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00968110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*